HY-P1376A-5mg
|
MedChemexpress LLC
|
G-Protein antagonist peptide (TFA)
|
|
Neuroscience-Neuromodulation
|
|
HY-146127A-1mg
|
MedChemexpress LLC
|
Grb2 SH2 domain inhibitor 1 (TFA)
|
|
|
|
HY-146127A-10mg
|
MedChemexpress LLC
|
Grb2 SH2 domain inhibitor 1 (TFA)
|
|
|
|
HY-146127A-5mg
|
MedChemexpress LLC
|
Grb2 SH2 domain inhibitor 1 (TFA)
|
|
|
|
HY-P99263-1mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99263-10mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99263-5mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-137872-1g
|
MedChemexpress LLC
|
L-Leucyl-4-nitroanilide (hydrochloride) [CAS 16010-98-3]
|
|
|
|
HY-137872-250mg
|
MedChemexpress LLC
|
L-Leucyl-4-nitroanilide (hydrochloride) [CAS 16010-98-3]
|
|
|
|
HY-P3328A-10mg
|
MedChemexpress LLC
|
MDP1 (acetate)
|
|
COVID-19-immunoregulation
|
|
HY-P3328A-25mg
|
MedChemexpress LLC
|
MDP1 (acetate)
|
|
COVID-19-immunoregulation
|
|
HY-P3328A-5mg
|
MedChemexpress LLC
|
MDP1 (acetate)
|
|
COVID-19-immunoregulation
|
|
HY-P3328A-50mg
|
MedChemexpress LLC
|
MDP1 (acetate)
|
|
COVID-19-immunoregulation
|
|